JW Pharmaceutical Corporation (KRX:001060)
25,000
-100 (-0.40%)
At close: Nov 14, 2025
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 573.07 billion as of November 14, 2025. Its market cap has decreased by -16.23% in one year.
Market Cap
573.07B
Enterprise Value
591.27B
Revenue
742.85B
Ranking
n/a
PE Ratio
11.83
Stock Price
25,000.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 573.07B, an increase of 582.04%. That is a compound annual growth rate of 8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 573.07B | 2.02% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 42.98T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 10.06T |
| Yuhan | 9.07T |
| ABL Bio | 9.01T |
| Peptron | 7.25T |
| HLB Co., Ltd. | 6.67T |